http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2425697-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e1ef8765fc83e2b0f07f225d689617e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-32 |
| filingDate | 2010-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a82f1ef1454681afda476155b6ed987b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1249a23eced1160eb1e70ff9fa21de42 |
| publicationDate | 2011-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2425697-C1 |
| titleOfInvention | Method of secondary prevention of degree i-ii arterial hypertension |
| abstract | FIELD: medicine. ^ SUBSTANCE: method involves a drug therapy. It is combined with daily transcranial electrostimulation. It implies rectangular pulse current exposure at the fixed frequency 77 Hz and duration 3.5-4.0 ms. For the first three procedures, the pulse single-polarity current is used; the current intensity is 0.5-1.0 mA. The following procedures use the pulse bipolar current intensity up to 2 mA. Duration of a procedure is 30 minutes. The therapeutic course is 10 procedures. ^ EFFECT: method reduces progression of the disease, promotes better remote therapeutic effect, reduces time of temporary and persistent disablement. ^ 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2756417-C1 |
| priorityDate | 2010-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.